Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

Colin A. J. Farquharson, Allan D. Struthers

    Research output: Contribution to journal › Article › peer-review

    512 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science